Analysts are estimating that CME Gr will report an earnings per share (EPS) of $2.95.
CME Gr bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Past Earnings Performance
In the previous earnings release, the company beat EPS by $0.01, leading to a 0.68% increase in the share price the following trading session.
Here's a look at CME Gr's past performance and the resulting price change:
Quarter
Q1 2025
Q4 2024
Q3 2024
Q2 2024
EPS Estimate
2.79
2.45
2.65
2.53
EPS Actual
2.80
2.52
2.68
2.56
Price Change %
1.0%
0.0%
1.0%
1.0%
CME Gr Share Price Analysis
Shares of CME Gr were trading at $275.0 as of July 21. Over the last 52-week period, shares are up 39.36%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
Analysts' Take on CME Gr
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on CME Gr.
Analysts have provided CME Gr with 10 ratings, resulting in a consensus rating of Neutral. The average one-year price target stands at $282.8, suggesting a potential ...
